|
1
|
The ubiquitin ligase COP1 is a critical negative regulator of p53.
|
Nature
|
2004
|
5.05
|
|
2
|
DUBA: a deubiquitinase that regulates type I interferon production.
|
Science
|
2007
|
3.88
|
|
3
|
Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase.
|
Science
|
2004
|
3.28
|
|
4
|
Automated de novo protein sequencing of monoclonal antibodies.
|
Nat Biotechnol
|
2008
|
3.02
|
|
5
|
Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1.
|
Mol Cell Biol
|
2009
|
2.26
|
|
6
|
Autophosphorylated CaMKIIalpha acts as a scaffold to recruit proteasomes to dendritic spines.
|
Cell
|
2010
|
2.02
|
|
7
|
Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1).
|
Biochem J
|
2009
|
1.94
|
|
8
|
Phosphorylation of NLRC4 is critical for inflammasome activation.
|
Nature
|
2012
|
1.92
|
|
9
|
COP1 is a tumour suppressor that causes degradation of ETS transcription factors.
|
Nature
|
2011
|
1.83
|
|
10
|
Improved quantitative mass spectrometry methods for characterizing complex ubiquitin signals.
|
Mol Cell Proteomics
|
2010
|
1.43
|
|
11
|
Phosphorylation-dependent activity of the deubiquitinase DUBA.
|
Nat Struct Mol Biol
|
2012
|
1.42
|
|
12
|
Ubiquitin binding to A20 ZnF4 is required for modulation of NF-κB signaling.
|
Mol Cell
|
2010
|
1.41
|
|
13
|
Targeted mass spectrometric strategy for global mapping of ubiquitination on proteins.
|
Rapid Commun Mass Spectrom
|
2007
|
1.21
|
|
14
|
Death-receptor activation halts clathrin-dependent endocytosis.
|
Proc Natl Acad Sci U S A
|
2006
|
1.18
|
|
15
|
De novo proteomic sequencing of a monoclonal antibody raised against OX40 ligand.
|
Anal Biochem
|
2006
|
1.12
|
|
16
|
Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodies.
|
J Mol Biol
|
2013
|
1.11
|
|
17
|
OTUB1 modulates c-IAP1 stability to regulate signalling pathways.
|
EMBO J
|
2013
|
1.09
|
|
18
|
Resurrection of a clinical antibody: template proteogenomic de novo proteomic sequencing and reverse engineering of an anti-lymphotoxin-α antibody.
|
Proteomics
|
2011
|
1.08
|
|
19
|
B and T lymphocyte attenuator regulates B cell receptor signaling by targeting Syk and BLNK.
|
J Immunol
|
2009
|
1.08
|
|
20
|
Mass spectrometric contributions to the practice of phosphorylation site mapping through 2003: a literature review.
|
Mol Cell Proteomics
|
2005
|
1.05
|
|
21
|
Template proteogenomics: sequencing whole proteins using an imperfect database.
|
Mol Cell Proteomics
|
2010
|
1.04
|
|
22
|
Furin-cleaved proprotein convertase subtilisin/kexin type 9 (PCSK9) is active and modulates low density lipoprotein receptor and serum cholesterol levels.
|
J Biol Chem
|
2012
|
0.99
|
|
23
|
Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics.
|
Mol Neurodegener
|
2014
|
0.93
|
|
24
|
Bioinformatics analysis of thousands of TCGA tumors to determine the involvement of epigenetic regulators in human cancer.
|
BMC Genomics
|
2015
|
0.88
|
|
25
|
Identifying potential therapeutic targets of methicillin-resistant Staphylococcus aureus through in vivo proteomic analysis.
|
J Infect Dis
|
2013
|
0.85
|
|
26
|
Proteome analysis of antibody-producing CHO cell lines with different metabolic profiles.
|
Biotechnol Bioeng
|
2007
|
0.84
|
|
27
|
Ubiquilin4 is an adaptor protein that recruits Ubiquilin1 to the autophagy machinery.
|
EMBO Rep
|
2013
|
0.84
|
|
28
|
Targeting interferon alpha subtypes in serum: a comparison of analytical approaches to the detection and quantitation of proteins in complex biological matrices.
|
J Proteome Res
|
2009
|
0.81
|
|
29
|
Proteomics.
|
Methods Enzymol
|
2005
|
0.80
|
|
30
|
Disulfide locked variants of factor VIIa with a restricted beta-strand conformation have enhanced enzymatic activity.
|
Protein Sci
|
2005
|
0.80
|